TGFB2 Antikörper (AA 304-413)
Kurzübersicht für TGFB2 Antikörper (AA 304-413) (ABIN7172823)
Target
Alle TGFB2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 304-413
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Transforming growth factor beta-2 proprotein protein (304-413AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TGFB2 (Transforming Growth Factor, beta 2 (TGFB2))
-
Andere Bezeichnung
- TGFB2
-
Hintergrund
-
Background: TGF-beta 2 has suppressive effects on interleukin-2 dependent T-cell growth.
Aliases: BSC-1 cell growth inhibitor antibody, BSC1 cell growth inhibitor antibody, Cetermin antibody, G-TSF antibody, Glioblastoma-derived T-cell suppressor factor antibody, GTSF antibody, LAP antibody, Latency-associated peptide antibody, MGC116892 antibody, MGF antibody, Milk growth factor antibody, Polyergin antibody, TGF-beta-2 antibody, TGF-beta2 antibody, TGFB2 antibody, TGFB2_HUMAN antibody, Transforming growth factor beta 2 antibody
-
UniProt
- P61812
-
Pathways
- Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus
Target
-